Cure8 research brief
Why This Matters
IBD is linked to higher skeletal risk; early biochemical changes in Wnt-pathway proteins might identify bone impairment before DXA detects low bone density, potentially helping earlier risk stratification.
Who Should Pay Attention
Adult patients with IBD (Crohn's disease or ulcerative colitis), gastroenterology clinicians managing bone health in IBD, and researchers studying bone biology and biomarkers in inflammatory disease.
Study Snapshot
What To Know
This is a cross-sectional, matched case–control study (89 IBD patients, 73 controls) reporting associations between serum Wnt-related proteins and inflammation, corticosteroid use, vitamin D, sex, and BMI. The study measured fasting serum sclerostin, DKK‑1, periostin, calcium, phosphorus, magnesium, 25(OH)D, plus lumbar spine and femoral BMD by DXA.
The findings suggest biochemical alterations in bone-regulating pathways in IBD that could reflect increased bone turnover despite preserved DXA results. As a preprint presented as an abstract/full-text on Europe PMC, these results are preliminary and have not completed peer review.
Keep In Mind
This report is a preprint/abstract-level cross-sectional study. It shows associations but cannot prove causation. Biomarker differences may reflect inflammation, medication (corticosteroid) use, or other factors; results should be confirmed in larger, peer-reviewed and longitudinal studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.